X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (78827) 78827
Book Review (10393) 10393
Publication (4862) 4862
Newsletter (2110) 2110
Newspaper Article (780) 780
Book / eBook (363) 363
Book Chapter (143) 143
Conference Proceeding (106) 106
Magazine Article (75) 75
Dissertation (56) 56
Trade Publication Article (6) 6
Government Document (5) 5
Paper (3) 3
Reference (2) 2
Transcript (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
Report (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (71668) 71668
humans (68637) 68637
female (39433) 39433
male (37744) 37744
middle aged (29813) 29813
oncology (29312) 29312
aged (24775) 24775
lung neoplasms - secondary (23064) 23064
lung neoplasms - pathology (22128) 22128
cancer (20833) 20833
adult (20104) 20104
lung cancer (16849) 16849
animals (16366) 16366
metastasis (14145) 14145
mice (11686) 11686
lung neoplasms - drug therapy (11478) 11478
chemotherapy (10529) 10529
cell line, tumor (10158) 10158
prognosis (10091) 10091
tumors (10001) 10001
research (9472) 9472
care and treatment (8936) 8936
aged, 80 and over (8731) 8731
surgery (8087) 8087
lung-cancer (7841) 7841
abridged index medicus (7648) 7648
treatment outcome (7618) 7618
neoplasm staging (7348) 7348
respiratory system (7242) 7242
expression (7169) 7169
lung cancer, non-small cell (7114) 7114
lung neoplasms - surgery (7020) 7020
analysis (6844) 6844
carcinoma (6793) 6793
lung neoplasms - genetics (6776) 6776
lung neoplasms - metabolism (6569) 6569
retrospective studies (6510) 6510
apoptosis (6153) 6153
survival (5967) 5967
carcinoma, non-small-cell lung - pathology (5950) 5950
lung (5818) 5818
antineoplastic combined chemotherapy protocols - therapeutic use (5690) 5690
health aspects (5681) 5681
cell lung-cancer (5577) 5577
lung neoplasms - mortality (5575) 5575
tomography, x-ray computed (5472) 5472
lung neoplasms - diagnostic imaging (5152) 5152
carcinoma, non-small-cell lung - drug therapy (5139) 5139
survival rate (5102) 5102
immunohistochemistry (5018) 5018
lung neoplasms - diagnosis (4935) 4935
lymphatic metastasis (4827) 4827
proteins (4725) 4725
breast-cancer (4699) 4699
diagnosis (4692) 4692
follow-up studies (4658) 4658
medicine & public health (4605) 4605
brain neoplasms - secondary (4590) 4590
lung neoplasms - therapy (4527) 4527
neoplasm metastasis (4524) 4524
antineoplastic agents - therapeutic use (4461) 4461
gene expression (4432) 4432
pathology (4418) 4418
liver neoplasms - secondary (4386) 4386
radiotherapy (4318) 4318
breast cancer (4293) 4293
radiology, nuclear medicine & medical imaging (4293) 4293
risk factors (4261) 4261
adenocarcinoma - secondary (4224) 4224
genetic aspects (4218) 4218
cancer therapies (4213) 4213
metastases (4167) 4167
cell biology (4136) 4136
mutation (3982) 3982
development and progression (3936) 3936
therapy (3899) 3899
gene expression regulation, neoplastic (3847) 3847
hematology, oncology and palliative medicine (3816) 3816
combined modality therapy (3771) 3771
adenocarcinoma - pathology (3755) 3755
medicine (3741) 3741
bone neoplasms - secondary (3735) 3735
time factors (3720) 3720
patients (3701) 3701
oncology, experimental (3682) 3682
breast neoplasms - pathology (3679) 3679
adolescent (3638) 3638
adenocarcinoma (3615) 3615
survival analysis (3513) 3513
diagnosis, differential (3502) 3502
research article (3482) 3482
article (3441) 3441
mice, nude (3431) 3431
biochemistry & molecular biology (3304) 3304
cell proliferation (3295) 3295
pharmacology & pharmacy (3279) 3279
carcinoma, non-small-cell lung - secondary (3236) 3236
disease-free survival (3196) 3196
antineoplastic agents - pharmacology (3136) 3136
medical prognosis (3089) 3089
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (298) 298
West Park Healthcare Centre - Stacks (15) 15
Collection Dvlpm't (Acquisitions) - Closed Orders (10) 10
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Online Resources - Online (6) 6
Scarborough Hospital - General (6) 6
Providence Healthcare - Reference (4) 4
Providence Healthcare - Stacks (4) 4
Humber River Regional Hospital - Church Stacks (3) 3
St. Michael's Hospital - Stacks (3) 3
Toronto East General Hospital - Stacks (3) 3
West Park Healthcare Centre - Hospital Department (3) 3
Gerstein Science - Missing (2) 2
Holland Bloorview Kids Rehabilitation - Stacks (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
Mt Sinai Hospital - Pathology (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Reference (2) 2
Earth Sciences (Noranda) - Stacks (1) 1
Gerstein Science - Not Returned (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Royal Ontario Museum - Periodical Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (75236) 75236
Japanese (2157) 2157
French (1057) 1057
German (1031) 1031
Chinese (717) 717
Spanish (599) 599
Russian (459) 459
Italian (297) 297
Polish (192) 192
Hungarian (68) 68
Czech (64) 64
Portuguese (62) 62
Danish (55) 55
Dutch (54) 54
Romanian (39) 39
Korean (32) 32
Turkish (30) 30
Croatian (26) 26
Hebrew (20) 20
Bulgarian (18) 18
Slovak (10) 10
Swedish (10) 10
Serbian (8) 8
Finnish (7) 7
Norwegian (7) 7
Lithuanian (5) 5
Ukrainian (4) 4
Icelandic (3) 3
Greek (2) 2
Bosnian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 83, Issue 3, pp. 878 - 886
Purpose To analyze the long-term survival and tumor control outcomes after stereotactic body radiotherapy (SBRT) for metastases limited in number and extent.... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic body radiotherapy | Breast cancer | Oligometastases | Survival | Metastases | ACR PRACTICE GUIDELINES | PHASE I/II TRIAL | HEPATIC RESECTION | CELL LUNG-CANCER | LIVER METASTASES | ONCOLOGY ASTRO | ONCOLOGY | COLORECTAL-CANCER | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | AMERICAN SOCIETY | RADIATION-THERAPY SBRT | TUMOR VOLUME | Bone Neoplasms - mortality | Sarcoma - secondary | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Carcinoma, Squamous Cell - surgery | Liver Neoplasms - mortality | Radiosurgery - adverse effects | Brain Neoplasms - surgery | Esophageal Neoplasms - pathology | Brain Neoplasms - secondary | Carcinoma, Squamous Cell - mortality | Lung Neoplasms - secondary | Sarcoma - mortality | Aged, 80 and over | Adult | Female | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Radiosurgery - methods | Colorectal Neoplasms - mortality | Neoplasm Metastasis - radiotherapy | Liver Neoplasms - surgery | Lymphatic Metastasis | Bone Neoplasms - surgery | Adenocarcinoma - secondary | Head and Neck Neoplasms - pathology | Breast Neoplasms - pathology | Sarcoma - surgery | Breast Neoplasms - mortality | Carcinoma, Squamous Cell - secondary | Lung Neoplasms - surgery | Aged | Head and Neck Neoplasms - mortality | Colorectal Neoplasms - pathology | Adenocarcinoma - mortality | Adenocarcinoma - surgery | Radiotherapy | Nuclear radiation | Analysis | Radiation | Index Medicus | MULTIVARIATE ANALYSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | METASTASES | RADIOLOGY AND NUCLEAR MEDICINE | DEATH | REGRESSION ANALYSIS | RADIOTHERAPY | HAZARDS | SKELETON
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2012, Volume 30, Issue 6, pp. 593 - 599
Journal Article
Nature Cell Biology, ISSN 1465-7392, 07/2013, Volume 15, Issue 7, pp. 807 - 817
Journal Article
Nature Communications, ISSN 2041-1723, 11/2015, Volume 6, Issue 1, pp. 8760 - 8760
Circulating tumour DNA analysis can be used to track tumour burden and analyse cancer genomes non-invasively but the extent to which it represents metastatic... 
HETEROGENEITY | ACTIVATION | VARIANTS | PATHWAY | MULTIDISCIPLINARY SCIENCES | KINASE | ACQUIRED-RESISTANCE | SEQUENCING DATA | Carcinoma, Ductal, Breast - genetics | Receptors, Estrogen - metabolism | Humans | Receptor, ErbB-2 - metabolism | Clonal Evolution - genetics | Tamoxifen - administration & dosage | Case-Control Studies | Breast Neoplasms - metabolism | Brain Neoplasms - secondary | Carcinoma, Ductal, Breast - drug therapy | Neoplasm Metastasis | Lung Neoplasms - secondary | Adult | Carcinoma, Ductal, Breast - pathology | Female | Quinazolines - administration & dosage | Liver Neoplasms - secondary | Carcinoma, Ductal, Breast - metabolism | Lung Neoplasms - genetics | Liver Neoplasms - genetics | Deoxycytidine - administration & dosage | Brain Neoplasms - genetics | Trastuzumab - administration & dosage | Breast Neoplasms - drug therapy | Sequence Analysis, DNA | Spinal Neoplasms - secondary | Breast Neoplasms - genetics | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Spinal Neoplasms - genetics | Bayes Theorem | DNA, Neoplasm - genetics | Mutation | Deoxycytidine - analogs & derivatives | Biological evolution | Breast cancer | Genomes | Metastasis | ErbB-2 protein | Patients | Metastases | Heterogeneity | Biopsy | Breast | Evolution | Deoxyribonucleic acid--DNA | Cancer | Tumors | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2016, Volume 68, pp. 156 - 162
Abstract Purpose To assess preliminary safety and efficacy results of the anti-programmed cell death ligand-1 (anti-PD-L1) durvalumab in combination with... 
Hematology, Oncology and Palliative Medicine | Immunoradiotherapy | Phase 2 | Phase 1 | Radiotherapy | Anti-PD-L1 | ABSCOPAL | ONCOLOGY | MECHANISMS | PATIENT | RADIATION-THERAPY | Lymphatic Metastasis - radiotherapy | Bone Neoplasms - therapy | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Carcinoma, Transitional Cell - secondary | Radiosurgery | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Carcinoma, Transitional Cell - therapy | Liver Neoplasms - therapy | Eye Neoplasms - therapy | Chemoradiotherapy | Small Cell Lung Carcinoma - secondary | Breast Neoplasms - therapy | Brain Neoplasms - secondary | Neoplasms - therapy | Squamous Cell Carcinoma of Head and Neck | Urinary Bladder Neoplasms - pathology | Aged, 80 and over | Adult | Female | Liver Neoplasms - secondary | Colonic Neoplasms - therapy | Eye Neoplasms - pathology | Head and Neck Neoplasms - therapy | Kaplan-Meier Estimate | Carcinoma, Squamous Cell - therapy | Survival Rate | Lung Neoplasms - therapy | Adenocarcinoma - secondary | Melanoma - secondary | Head and Neck Neoplasms - pathology | Disease-Free Survival | B7-H1 Antigen - antagonists & inhibitors | Adenocarcinoma - therapy | Breast Neoplasms - pathology | Colonic Neoplasms - pathology | Urinary Bladder Neoplasms - therapy | Brain Neoplasms - therapy | Radiotherapy, Conformal | Aged | Small Cell Lung Carcinoma - therapy | Melanoma - therapy | Biochemistry | Apoptosis | Index Medicus
Journal Article
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 65, Issue 2, pp. 270 - 273
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 03/2013, Volume 8, Issue 3, pp. 346 - 351
Journal Article
American Journal of Pathology, ISSN 0002-9440, 2010, Volume 177, Issue 4, pp. 1647 - 1656
Phosphatase and tensin homolog (PTEN) is a key modulator of trastuzumab sensitivity in HER2-overexpressing breast cancer. Because PTEN opposes the downstream... 
ADJUVANT CHEMOTHERAPY | CELLS | INHIBITION | THERAPY | HUMAN-BREAST-CANCER | MUTATIONS | PATHOLOGY | RECEPTORS | TRASTUZUMAB RESISTANCE | EXPRESSION | CARCINOMA | Lung Neoplasms - drug therapy | Receptors, Estrogen - metabolism | Receptor, ErbB-2 - genetics | Lung Neoplasms - mortality | Humans | Middle Aged | Bone Neoplasms - secondary | Antibodies, Monoclonal - therapeutic use | Immunoenzyme Techniques | Receptors, Progesterone - metabolism | Young Adult | Carcinoma, Ductal, Breast - drug therapy | Brain Neoplasms - mortality | Liver Neoplasms - secondary | Proto-Oncogene Proteins c-akt - metabolism | Carcinoma, Ductal, Breast - metabolism | PTEN Phosphohydrolase - genetics | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Survival Rate | Lymphatic Metastasis | Brain Neoplasms - drug therapy | Mutation - genetics | Breast Neoplasms - drug therapy | Class I Phosphatidylinositol 3-Kinases | Carcinoma, Lobular - metabolism | Trastuzumab | Bone Neoplasms - mortality | Phosphorylation | Prognosis | Receptor, ErbB-2 - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Liver Neoplasms - mortality | Carcinoma, Ductal, Breast - mortality | Carcinoma, Lobular - mortality | Breast Neoplasms - metabolism | Antibodies, Monoclonal, Humanized | Brain Neoplasms - secondary | In Situ Hybridization | Lung Neoplasms - secondary | Adult | Female | Bone Neoplasms - drug therapy | Neoplasm Invasiveness | Liver Neoplasms - drug therapy | PTEN Phosphohydrolase - metabolism | Phosphatidylinositol 3-Kinases - genetics | Breast Neoplasms - mortality | Aged | Carcinoma, Lobular - drug therapy | Index Medicus | Abridged Index Medicus | Regular
Journal Article